Literature DB >> 10843298

Active cocaine immunization attenuates the discriminative properties of cocaine.

M W Johnson1, R H Ettinger.   

Abstract

Anticocaine antibody, resulting from immunization with the cocaine-keyhole-limpet-hemocyanin (KLH) conjugate, weakened the ability of cocaine to act as a discriminative stimulus in rats. Subjects were given extensive training to discriminate 5.0 mg/kg of cocaine from saline prior to immunization. Several weeks following immunization with cocaine-KLH, subjects failed to reliably discriminate cocaine from saline. Nonimmunized control rats retained the ability to discriminate cocaine from saline throughout the experiment. These results further demonstrate that active immunization is effective in blunting cocaine effects. Immunized subjects were able to discriminate 20 mg/kg of cocaine, however, suggesting that anticocaine antibody may be overwhelmed by large cocaine doses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843298     DOI: 10.1037//1064-1297.8.2.163

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  10 in total

1.  Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization.

Authors:  Therese A Kosten; Xiaoyun Y Shen; Berma M Kinsey; Thomas R Kosten; Frank M Orson
Journal:  Am J Addict       Date:  2014-09-22

Review 2.  The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.

Authors:  Matthew W Johnson; Roland R Griffiths; Peter S Hendricks; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2018-06-05       Impact factor: 5.250

3.  Active immunotherapy for the Treatment of Cocaine Dependence.

Authors:  Berma M Kinsey; Thomas R Kosten; Frank M Orson
Journal:  Drugs Future       Date:  2010-04-01       Impact factor: 0.148

4.  Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence.

Authors:  Anna Carfora; Paola Cassandro; Alessandro Feola; Francesco La Sala; Raffaella Petrella; Renata Borriello
Journal:  J Bioeth Inq       Date:  2018-01-19       Impact factor: 1.352

Review 5.  Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users.

Authors:  Stephen Brimijoin
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

6.  AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.

Authors:  Jonathan B Rosenberg; Martin J Hicks; Bishnu P De; Odelya Pagovich; Esther Frenk; Kim D Janda; Sunmee Wee; George F Koob; Neil R Hackett; Stephen M Kaminsky; Stefan Worgall; Nicole Tignor; Jason G Mezey; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2012-05       Impact factor: 5.695

Review 7.  Anti-cocaine vaccine development.

Authors:  Berma M Kinsey; Thomas R Kosten; Frank M Orson
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

8.  Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans.

Authors:  Margaret Haney; Erik W Gunderson; Huiping Jiang; Eric D Collins; Richard W Foltin
Journal:  Biol Psychiatry       Date:  2010-01-01       Impact factor: 13.382

Review 9.  Vaccines against drugs of abuse: a viable treatment option?

Authors:  Kathleen M Kantak
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence.

Authors:  W Hall; L Carter
Journal:  J Med Ethics       Date:  2004-08       Impact factor: 2.903

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.